Development and Validation of a Multiparameterized Artificial Neural Network for Prostate Cancer Risk Prediction and Stratification.
暂无分享,去创建一个
Jun Deng | Gregory R. Hart | David A. Roffman | Gregory R Hart | James B Yu | Issa Ali | James B. Yu | M. Leapman | Issa Ali | David A Roffman | Michael S Leapman | Fangliang L Guo | J. Deng | F. Guo
[1] Andrew J. Vickers,et al. NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016. , 2016, Journal of the National Comprehensive Cancer Network : JNCCN.
[2] Jun Deng,et al. Predicting non-melanoma skin cancer via a multi-parameterized artificial neural network , 2018, Scientific Reports.
[3] K. Bibbins-Domingo,et al. The US Preventive Services Task Force 2017 Draft Recommendation Statement on Screening for Prostate Cancer: An Invitation to Review and Comment. , 2017, JAMA.
[4] B. Henderson,et al. Association of diabetes with prostate cancer risk in the multiethnic cohort. , 2009, American journal of epidemiology.
[5] P. Lambin,et al. Machine Learning methods for Quantitative Radiomic Biomarkers , 2015, Scientific Reports.
[6] R. Severson,et al. Body mass and prostatic cancer: a prospective study. , 1988, BMJ.
[7] A. Pollack,et al. Ethnic heterogeneity and prostate cancer mortality in Hispanic/Latino men: a population-based study , 2017, Oncotarget.
[8] I. Kohane,et al. Development of phenotype algorithms using electronic medical records and incorporating natural language processing , 2015, BMJ : British Medical Journal.
[9] R. Deyo,et al. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.
[10] Xiangyi Zheng,et al. Hypertension and risk of prostate cancer: a systematic review and meta-analysis , 2016, Scientific Reports.
[11] G. Matheson,et al. Exercise and Prostate Cancer , 2004, Sports medicine.
[12] P. Sasieni,et al. Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[13] H. D. de Koning,et al. Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice: A microsimulation screening analysis , 2016, Cancer.
[14] Klaus Jung,et al. Multicenter evaluation of an artificial neural network to increase the prostate cancer detection rate and reduce unnecessary biopsies. , 2002, Clinical chemistry.